Platinum-based chemotherapeutic agent and thymidylate synthase inhibitor

This page covers all Platinum-based chemotherapeutic agent and thymidylate synthase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Thymidylate synthase, DNA.

Targets

Thymidylate synthase · DNA

Phase 3 pipeline (1)

• oxaliplatin , fluorouracil, and leucovorin · Sun Yat-sen University · Oncology
  Oxaliplatin, fluorouracil, and leucovorin work together to inhibit thymidylate synthase and DNA synthesis, leading to cell death in rapidly dividing cancer cells.

Phase 2 pipeline (1)

• Adjuvant FOLFOX · Asan Medical Center · Oncology
  Oxaliplatin and 5-fluorouracil inhibit DNA replication and transcription by cross-linking DNA and interfering with thymidylate synthase.

Patent intelligence

• platinum based chemotherapeutic agent and thymidylate synthase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates